TECX Tectonic Therapeutic

• $182K bought by 2 insiders
• None no sales outside a trading plan
• $651K sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Peter McNamara Chief Scientific Officer
   Planned sale
   $12K 536 shares at $23.04 1% of stake
   Traded Sep 30 Filed Oct 2
   ↗
3. Peter McNamara Chief Scientific Officer
   Planned sale
   $1,570 43 shares at $36.52 0.1% of stake
   Traded Aug 25 Filed Aug 26
   ↗
4. Peter McNamara Chief Scientific Officer
   Planned sale
   $1,505 43 shares at $35.00 0.1% of stake
   Traded Aug 12 Filed Aug 14
   ↗
5. Peter McNamara Chief Scientific Officer
   Planned sale
   $6,020 172 shares at $35.00 0.3% of stake
   Traded Jun 30 Filed Jul 1
   ↗
6. Marcella K. Ruddy Chief Medical Officer
   Planned sale
   $32K 1,065 shares at $30.00 1.5% of stake
   Traded May 4 Filed May 6
   ↗
7. Marcella K. Ruddy Chief Medical Officer
   Planned sale
   $31K 1,000 shares at $31.05 1.4% of stake
   Traded Apr 1 Filed Apr 3
   ↗
8. Marcella K. Ruddy Chief Medical Officer
   Planned sale
   $300K 10,000 shares at $30.00 13% of stake
   Traded Mar 6 Filed Mar 9
   ↗
9. Peter McNamara Chief Scientific Officer
   Planned sale
   $189K 6,262 shares at $30.17 10% of stake
   Traded Mar 6 Filed Mar 9
   ↗
10. Peter McNamara Chief Scientific Officer
    Planned sale
    $78K 3,299 shares at $23.53 5.3% of stake
    Traded Mar 3–4 Filed Mar 5
    ↗
11. Alise Reicin CEO
    Buy
    $53K 2,500 shares at $21.10 +2% to stake
    Traded Feb 11 Filed Mar 5
    ↗
12. Daniel Lochner CFO
    Buy
    $130K 6,000 shares at $21.61 +23% to stake
    Traded Feb 10 Filed Feb 11
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 share withholdings for taxes, 8 option exercises, and 5 stock grants.